NORCROSS, Ga., May 11 /PRNewswire/ -- Regent Medical Americas, the North American arm of Regent Medical Ltd, the only major medical glove company with an exclusively powder-free medical glove line, announces completion of Regent Medical Ltd’s merger with Molnlycke Health Care and Medlock Medical, creating a leading medical products group, Molnlycke Health Care Group, with a strong brand focus.
According to Lundy Fields, formerly Regent Medical Americas President and now Molnlycke Health Care US President, the merger of Gothenburg, Sweden-based Molnlycke Health Care with two Manchester, UK-based companies (Regent Medical and Medlock Medical), results in a new force in global healthcare. “The compelling strategic fit between Molnlycke and Regent, a leading surgical supplier known for its two brands -- Biogel(R) powder-free surgical gloves and HIBICLENS(R) antiseptic/antimicrobial skin cleanser, and Medlock, a niche wound care company, creates a company with a significantly enhanced product range and opportunity in the market,” Fields said.
The company’s two strategic divisions will be Surgical and Wound Care. Focusing on prevention of surgically-related infections for both patients and healthcare workers, the Surgical Division will encompass the world’s leading manufacturer and supplier of powder-free surgical gloves (Biogel(R) surgical gloves) and the number one supplier (by value) of skin cleanser (Hibiclens(R) and Hibistat(R) antiseptics). A leader in trauma and pain management, the Wound Care Division’s market dynamics are driven by an aging population, higher incidence of pressure ulcers and increased home treatment.
There are clear synergies between the companies in terms of sales force and distribution as well as in R&D. This, together with a more decentralized approach by management, will see the opportunities for cost savings, increased profitability and an accelerated top line growth.
Commenting on the new strategy, Molnlycke CEO John Samuel said, “The platform for future growth is in place and now it is time for us to focus on improving and expanding our business. Our strategy is two-fold: In Surgical, we plan to take advantage of the growing market need for single use products and further expand geographically; and in Wound Care, we plan to grow the advanced wound care business from the strong base of the market leading Safetac(R) technology both with innovative new products and further geographical spread.”
Molnlycke Health Care
CONTACT: Juliann Kaiser, +1-770-643-1807, or jkaiser@linksg.com, forMolnlycke Health Care
